Safe fetal platelet genotyping: New developments

Transfusion

Volumn 53, Issue 8, 2013, Pages 1755-1762

  Le Toriellec, Emilie ^a   Chenet, Christophe ^a   Kaplan, Cecile ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS RISK; GENOTYPE; HUMAN; MALE; MATERNAL BLOOD; PREGNANCY; PREGNANT WOMAN; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANTIGENS, HUMAN PLATELET; COHORT STUDIES; FEMALE; GENETIC MARKERS; GENETIC TESTING; GENOTYPING TECHNIQUES; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL DIAGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84882456606     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03954.x     Document Type: Article

References (11)

1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS,. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
2. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM,. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
3. Bischoff FZ, Nguyen DD, Marquéz-Do D, Moise KJ Jr, Simpson JL, Elias S,. Noninvasive determination of fetal RhD status using fetal DNA in maternal serum and PCR. J Soc Gynecol Investig 1999; 6: 2-64.
4. Harper TC, Finning KM, Martin P, Moise KJ Jr,. Use of maternal plasma for noninvasive determination of fetal RhD status. Am J Obstet Gynecol 2004; 191: 1730-1732.
5. Scheffer PG, Soussan AA, Verhagen OJ, Page-Christiaens GC, Oepkes D, de, Haas M, van der, Schoot CE,. Noninvasive fetal genotyping of human platelet antigen-1a. BJOG 2011; 118: 1392-1395.
6. Liew M, Nelson L, Margraf R, Mitchell S, Erali M, Mao R, Lyon E, Wittwer C,. Genotyping of human platelet antigens 1 to 6 and 15 by high-resolution amplicon melting and conventional hybridization probes. J Mol Diagn 2006; 8: 97-104.
7. Ficko T, Galvani V, Rupreht R, Dovc T, Rozman P,. Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSP method. Transfus Med 2004; 14: 425-432.
8. Scheffer PG, de Haas M, van der Schoot CE,. The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. Curr Opin Hematol 2011; 18: 467-473.
9. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM,. Hypermethylated RASSF 1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006; 52: 2211-2218.
10. Hyland CA, Gardener GJ, Davies H, Ahvenainen M, Flower RL, Irwin D, Morris JM, Ward CM, Hyett JA,. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 2009; 191: 21-25.
11. Agathanggelou A, Cooper WN, Latif F,. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65: 3497-3508.